DIS
41
2
RIG
28
3
VRTX
69
-2
MLM
72
2
WBA
24
-3
ADSK
75
10
SCHW
43
-2
CCI
34
-7
NEE
44
-2
OKE
55
2
AAL
20
2
AEP
54
-2
SWKS
60
-5
SE
58
11
D
32
-5
AES
51
-4
ZION
44
3
IR
72
3
LMT
37
-2
TSCO
62
3
DIS
41
2
RIG
28
3
VRTX
69
-2
MLM
72
2
WBA
24
-3
ADSK
75
10
SCHW
43
-2
CCI
34
-7
NEE
44
-2
OKE
55
2
AAL
20
2
AEP
54
-2
SWKS
60
-5
SE
58
11
D
32
-5
AES
51
-4
ZION
44
3
IR
72
3
LMT
37
-2
TSCO
62
3
Financhill
Back

Devon Energy Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
18

DVN
Devon Energy

Last Price:
45.77
Seasonality Move:
1.79%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
18
Devon Energy (DVN) is a Sell

Is Devon Energy a Buy, Sell or Hold?

  • The current Devon Energy [DVN] share price is $45.76. The Score for DVN is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • DVN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DVN Stock Price Chart

What is Devon Energy's stock price today?

  • The Devon Energy share price today is $45.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DVN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

DVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.05 Sell
Relative Strength Index (14 RSI): 33.88 Sell
Chaikin Money Flow: 4636149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.5 - 49.36) Sell
Bollinger Bands (100): (44.04 - 51.44) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

DVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.49 Sell
20-day SMA: 47.5 Sell
50-day SMA: 49.97 Sell
200-day SMA: 47 Sell
8-day EMA: 46.38 Sell
20-day EMA: 47.41 Sell
50-day EMA: 48.44 Sell
200-day EMA: 48.36 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Devon Energy Earnings Growth & DVN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.43 per share, and an increase next year of $0.42 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Devon Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):